Loading ...
Sorry, an error occurred while loading the content.
 

Starvation Hormone Markedly Extends Mouse Life Span, Without Need for Calorie Restriction

Expand Messages
  • Eric Anderson
    Could this be given to humans at age 60?  Would it also extend lifespans? What other changes were observed that might aid in living a longer and more healthy
    Message 1 of 2 , Oct 16, 2012

      Could this be given to humans at age 60?  Would it also extend lifespans? What other changes were observed that might aid in living a longer and more healthy life? Would this work with the C-60 buckyball diet? Maybe as an add more or multiply effect?  What would be the rates of cancer, heart disease and or dementia? Comments?

       

      Starvation Hormone Markedly Extends Mouse Life Span, Without Need for Calorie Restriction

      ScienceDaily (Oct. 16, 2012) — A study by UT Southwestern Medical Center researchers finds that a starvation hormone markedly extends life span in mice without the need for calorie restriction.

       

      "Restricting food intake has been shown to extend lifespan in several different kinds of animals. In our study, we found transgenic mice that produced more of the hormone fibroblast growth factor-21 (FGF21) got the benefits of dieting without having to limit their food intake. Male mice that overproduced the hormone had about a 30 percent increase in average life span and female mice had about a 40 percent increase in average life span," said senior author Dr. Steven Kliewer, professor of molecular biology and pharmacology.
      The study published online in eLife -- a new peer-reviewed, open access journal -- defined average life span as the point at which half the members of a given test group remained alive. A study to determine differences in maximum life span is ongoing: While none of the untreated mice lived longer than about 3 years, some of the female mice that overproduced FGF21 were still alive at nearly 4 years, the researchers report.
      FGF21 seems to provide its health benefits by increasing insulin sensitivity and blocking the growth hormone/insulin-like growth factor-1 signaling pathway. When too abundant, growth hormone can contribute to insulin resistance, cancer, and other diseases, the researchers said.
      FGF21 is a hormone secreted by the liver during fasting that helps the body adapt to starvation. It is one of three growth factors that are considered atypical because they behave like hormones, which are substances created by one part of the body that have effects in other parts, the researchers said.
      "Prolonged overproduction of the hormone FGF21 causes mice to live extraordinary long lives without requiring a decrease in food intake. It mimics the health benefits of dieting without having to diet," said co-author Dr. David Mangelsdorf, chairman of pharmacology and a Howard Hughes Medical Institute (HHMI) investigator at UT Southwestern.
      "Aging and aging-related diseases represent an increasing burden on modern society. Drugs that slow the aging process would be very desirable. These findings raise the possibility of a hormone therapy to extend life span," said Dr. Mangelsdorf, who runs a research laboratory with Dr. Kliewer. They first identified FGF21's starvation-fighting effects in a 2007 study.
      Lead author Dr. Yuan Zhang, an instructor of pharmacology, said the study was considered risky because all involved understood it would be at least two years -- an average mouse life span -- before there would be any evidence of whether elevated production of FGF21 would affect longevity.
      Previous research has found that FGF21 can reduce weight in obese mice. The mice that overproduced FGF21 in this latest study were lean throughout their lives and remained lean even while eating slightly more than the wild-type mice, the researchers said.
      The hormone does have some downsides: FGF21 overproducers tended to be smaller than wild-type mice and the female mice were infertile. While FGF21 overproducers had significantly lower bone density than wild-type mice, the FGF21-abundant mice exhibited no ill effects from the reduced bone density and remained active into old age without any broken bones, the researchers said.
      "FGF21 is not affecting their mobility. These guys are spry. They live nice, long lives," Dr. Kliewer said. "But the decreased bone density and female infertility will require additional research to determine if it is possible to separate out the hormone's life span-extending effects from its effect on bone," he added.
      The study was supported by the National Institutes of Health, the Robert A. Welch Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, and the HHMI.
      UT Southwestern co-authors are Dr. Yang Xie, assistant professor of clinical sciences; Dr. Eric Berglund, postdoctoral researcher in the Division of Hypothalamic Research; Dr. Katie Colbert Coate, postdoctoral researcher in pharmacology; Dr. Tian Teng He, senior research associate in the Advanced Imaging Research Center; Dr. Takeshi Katafuchi, instructor of pharmacology; Dr. Guanghua Xiao, assistant professor of clinical sciences; Drs. Matthew Potthoff and Wei Wei, both postdoctoral researchers in pharmacology; and Dr. Yihong Wan, assistant professor of pharmacology. Drs. Ruth Yu and Ronald Evans of the Salk Institute in San Diego also participated in the research.
      Share this story on Facebook, Twitter, and Google:
      Other social bookmarking and sharing tools:
      |

      Story Source:
      The above story is reprinted from materials provided by UT Southwestern Medical Center.
      Note: Materials may be edited for content and length. For further information, please contact the source cited above.

      Journal Reference:
      1. Yuan Zhang, Yang Xie, Eric D Berglund, Katie Colbert Coate, Tian Teng He, Takeshi Katafuchi, Guanghua Xiao, Matthew J Potthoff, Wei Wei, Yihong Wan, Ruth T Yu, Ronald M Evans, Steven A Kliewer, David J Mangelsdorf. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. eLife, 2012; 1 DOI: 10.7554/eLife.00065
    • Eric Anderson
      In the next 18 years will we make more progress to increase lifespan one or more years for each year that goes by? This is one of several areas of research
      Message 2 of 2 , Dec 29, 2012
        In the next 18 years will we make more progress to increase lifespan one or more years for each year that goes by? This is one of several areas of research that may be part of the progress. IMO it provides a potential marker for interventions like alternate day eating.  Does eating every other day increase this marker? Decrease IGF-1? control glucose and insulin? Lower heart disease and cancer rates? Comments? Happy 2013 Eric from the SALT pits
         

        Starvation Hormone Markedly Extends Mouse Life Span, Without Need for Calorie Restriction

        Oct. 16, 2012 — A study by UT Southwestern Medical Center researchers finds that a starvation hormone markedly extends life span in mice without the need for calorie restriction.

         
        "Restricting food intake has been shown to extend lifespan in several different kinds of animals. In our study, we found transgenic mice that produced more of the hormone fibroblast growth factor-21 (FGF21) got the benefits of dieting without having to limit their food intake. Male mice that overproduced the hormone had about a 30 percent increase in average life span and female mice had about a 40 percent increase in average life span," said senior author Dr. Steven Kliewer, professor of molecular biology and pharmacology.
        The study published online in eLife -- a new peer-reviewed, open access journal -- defined average life span as the point at which half the members of a given test group remained alive. A study to determine differences in maximum life span is ongoing: While none of the untreated mice lived longer than about 3 years, some of the female mice that overproduced FGF21 were still alive at nearly 4 years, the researchers report.
        FGF21 seems to provide its health benefits by increasing insulin sensitivity and blocking the growth hormone/insulin-like growth factor-1 signaling pathway. When too abundant, growth hormone can contribute to insulin resistance, cancer, and other diseases, the researchers said.
        FGF21 is a hormone secreted by the liver during fasting that helps the body adapt to starvation. It is one of three growth factors that are considered atypical because they behave like hormones, which are substances created by one part of the body that have effects in other parts, the researchers said.
        "Prolonged overproduction of the hormone FGF21 causes mice to live extraordinary long lives without requiring a decrease in food intake. It mimics the health benefits of dieting without having to diet," said co-author Dr. David Mangelsdorf, chairman of pharmacology and a Howard Hughes Medical Institute (HHMI) investigator at UT Southwestern.
        "Aging and aging-related diseases represent an increasing burden on modern society. Drugs that slow the aging process would be very desirable. These findings raise the possibility of a hormone therapy to extend life span," said Dr. Mangelsdorf, who runs a research laboratory with Dr. Kliewer. They first identified FGF21's starvation-fighting effects in a 2007 study.
        Lead author Dr. Yuan Zhang, an instructor of pharmacology, said the study was considered risky because all involved understood it would be at least two years -- an average mouse life span -- before there would be any evidence of whether elevated production of FGF21 would affect longevity.
        Previous research has found that FGF21 can reduce weight in obese mice. The mice that overproduced FGF21 in this latest study were lean throughout their lives and remained lean even while eating slightly more than the wild-type mice, the researchers said.
        The hormone does have some downsides: FGF21 overproducers tended to be smaller than wild-type mice and the female mice were infertile. While FGF21 overproducers had significantly lower bone density than wild-type mice, the FGF21-abundant mice exhibited no ill effects from the reduced bone density and remained active into old age without any broken bones, the researchers said.
        "FGF21 is not affecting their mobility. These guys are spry. They live nice, long lives," Dr. Kliewer said. "But the decreased bone density and female infertility will require additional research to determine if it is possible to separate out the hormone's life span-extending effects from its effect on bone," he added.
        The study was supported by the National Institutes of Health, the Robert A. Welch Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, and the HHMI.
        UT Southwestern co-authors are Dr. Yang Xie, assistant professor of clinical sciences; Dr. Eric Berglund, postdoctoral researcher in the Division of Hypothalamic Research; Dr. Katie Colbert Coate, postdoctoral researcher in pharmacology; Dr. Tian Teng He, senior research associate in the Advanced Imaging Research Center; Dr. Takeshi Katafuchi, instructor of pharmacology; Dr. Guanghua Xiao, assistant professor of clinical sciences; Drs. Matthew Potthoff and Wei Wei, both postdoctoral researchers in pharmacology; and Dr. Yihong Wan, assistant professor of pharmacology. Drs. Ruth Yu and Ronald Evans of the Salk Institute in San Diego also participated in the research.
        Share this story on Facebook, Twitter, and Google:
        Other social bookmarking and sharing tools:

        Story Source:
        The above story is reprinted from materials provided by UT Southwestern Medical Center.
        Note: Materials may be edited for content and length. For further information, please contact the source cited above.

        Journal Reference:
        1. Yuan Zhang, Yang Xie, Eric D Berglund, Katie Colbert Coate, Tian Teng He, Takeshi Katafuchi, Guanghua Xiao, Matthew J Potthoff, Wei Wei, Yihong Wan, Ruth T Yu, Ronald M Evans, Steven A Kliewer, David J Mangelsdorf. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. eLife, 2012; 1 DOI: 10.7554/eLife.00065
      Your message has been successfully submitted and would be delivered to recipients shortly.